Cargando…

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)

ABTRACT: BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) includes a wide spectrum of liver diseases, ranging from pure steatosis to nonalcoholic steatohepatitis (NASH), and eventually to liver cirrhosis with its complications. Identifying advanced fibrosis in patients is crucial to evaluating p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raszeja-Wyszomirska, Joanna, Szymanik, Barbara, Ławniczak, Małgorzata, Kajor, Maciej, Chwist, Alina, Milkiewicz, Piotr, Hartleb, Marek
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905324/ https://www.ncbi.nlm.nih.gov/pubmed/20584330 http://dx.doi.org/10.1186/1471-230X-10-67

Ejemplares similares

Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction
por: Krawczyk, Marcin, et al.
Publicado: (2018)

Vitamin D Receptor Polymorphisms Predispose to Primary Biliary Cirrhosis and Severity of the Disease in Polish Population
por: Kempińska-Podhorecka, Agnieszka, et al.
Publicado: (2012)

Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR)
por: Stachowska, Ewa, et al.
Publicado: (2016)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients
por: Kruk, Beata, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2022)

Liver Injury Induced by High-Dose Methylprednisolone Therapy: A Case Report and Brief Review of the Literature
por: Gutkowski, Krzysztof, et al.
Publicado: (2011)

The Association between SOCS1−1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2019)

Factors Affecting Exercise Test Performance in Patients After Liver Transplantation
por: Kotarska, Katarzyna, et al.
Publicado: (2016)

Ferroportin-related haemochromatosis associated with novel Y64H mutation of the SCL40A1 gene
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2014)

TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary Cirrhosis
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2013)

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC
por: Kruk, Beata, et al.
Publicado: (2018)

Leisure time physical activity and health-related behaviours after liver transplantation: a prospective, single-centre study
por: Kotarska, Katarzyna, et al.
Publicado: (2015)

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Lee, Tae Hoon, et al.
Publicado: (2013)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

Factors Affecting Health-Related Quality of Life and Physical Activity after Liver Transplantation for Autoimmune and Nonautoimmune Liver Diseases: A Prospective, Single Centre Study
por: Kotarska, Katarzyna, et al.
Publicado: (2014)

A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients
por: Paziewska, Agnieszka, et al.
Publicado: (2017)

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example
por: Klonowska, Katarzyna, et al.
Publicado: (2015)

Long-Term Health-Related Quality of Life in Living Liver Donors
por: Janik, Maciej K., et al.
Publicado: (2019)

Etiology of Liver Disease and Cardiovascular Abnormalities in Patients on a Liver Transplantation Waiting List
por: Galas, Michalina, et al.
Publicado: (2019)

Severe viral oesophagitis, pharyngitis, and stomatitis as antecedents of ileocecal Crohn's disease
por: Boryczka, Grzegorz, et al.
Publicado: (2015)

Chronotropic incompetence in end-stage liver disease
por: Główczyńska, Renata, et al.
Publicado: (2022)

Orthotopic liver transplantation (OLTx) in non-cirrhotic portal hypertension secondary to ADAMTS13 deficiency
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2015)

5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
por: Banaszczak, Marcin, et al.
Publicado: (2020)

Hepatic angiogenesis and fibrosis are common features in morbidly obese patients
por: Ciupińska-Kajor, Monika, et al.
Publicado: (2011)

The Pre-Transplant Profile of Cardiovascular Risk Factors and Its Impact on Long-Term Mortality After Liver Transplantation
por: Główczyńska, Renata, et al.
Publicado: (2018)

Pretransplant QT Interval: The Relationship with Severity and Etiology of Liver Disease and Prognostic Value After Liver Transplantation
por: Główczyńska, Renata, et al.
Publicado: (2018)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
por: Carulli, Lucia, et al.
Publicado: (2019)

Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores
por: YENDEWA, George A., et al.
Publicado: (2023)

Good outcome following liver transplantation using pericardial-peritoneum window for hepato-atrial anastomosis to overcome advanced hepatic alveolar echinococcosis and secondary Budd-Chiari Syndrome - a case report
por: Kobryń, Konrad, et al.
Publicado: (2017)

Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis
por: Liebe, Roman, et al.
Publicado: (2016)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey
por: Hartleb, Marek, et al.
Publicado: (2021)

Osteoporosis in primary biliary cirrhosis of the liver
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2014)

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Eder, Piotr, et al.
Publicado: (2023)

Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Łodyga, Michał, et al.
Publicado: (2021)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_23j4en3s23lgs5q6bvhuksg201